- Home
- BWAY vs OCFT Comparison
BWAY vs OCFT Comparison
Compare BWAY & OCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWAY
- OCFT
- Stock Information
- Founded
- BWAY 2003
- OCFT 2015
- Country
- BWAY Israel
- OCFT China
- Employees
- BWAY N/A
- OCFT N/A
- Industry
- BWAY Medical/Dental Instruments
- OCFT Computer Software: Programming Data Processing
- Sector
- BWAY Health Care
- OCFT Technology
- Exchange
- BWAY Nasdaq
- OCFT Nasdaq
- Market Cap
- BWAY 201.1M
- OCFT 236.7M
- IPO Year
- BWAY 2019
- OCFT 2019
- Fundamental
- Price
- BWAY $10.22
- OCFT $7.09
- Analyst Decision
- BWAY Strong Buy
- OCFT
- Analyst Count
- BWAY 2
- OCFT 0
- Target Price
- BWAY $14.25
- OCFT N/A
- AVG Volume (30 Days)
- BWAY 34.0K
- OCFT 72.9K
- Earning Date
- BWAY 05-13-2025
- OCFT 05-28-2025
- Dividend Yield
- BWAY N/A
- OCFT N/A
- EPS Growth
- BWAY N/A
- OCFT N/A
- EPS
- BWAY 0.08
- OCFT N/A
- Revenue
- BWAY $43,457,000.00
- OCFT $260,815,958.00
- Revenue This Year
- BWAY $351.53
- OCFT N/A
- Revenue Next Year
- BWAY $21.84
- OCFT $6.37
- P/E Ratio
- BWAY $51.42
- OCFT N/A
- Revenue Growth
- BWAY 26.86
- OCFT N/A
- 52 Week Low
- BWAY $5.67
- OCFT $0.87
- 52 Week High
- BWAY $11.79
- OCFT $7.38
- Technical
- Relative Strength Index (RSI)
- BWAY 56.53
- OCFT 65.88
- Support Level
- BWAY $10.15
- OCFT $7.01
- Resistance Level
- BWAY $11.06
- OCFT $7.28
- Average True Range (ATR)
- BWAY 0.51
- OCFT 0.20
- MACD
- BWAY 0.00
- OCFT 0.00
- Stochastic Oscillator
- BWAY 54.72
- OCFT 69.15
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a technology-as-a-service provider for the financial services industry. It integrates extensive expertise in the industry with market technology to provide technology applications and technology-enabled business services to financial institutions. The integrated solutions and platforms it provides include digital banking solutions, digital insurance solutions, and the Gamma Platform, a technology infrastructure platform for financial institutions. Geographically, the company generates substantially all of its revenue from its business in the People's Republic of China (PRC).